S1P2 aggravates disease pathogenesis of bleomycin-induced pulmonary fibrosis by producing proinflammatory mediators, including TNF-α, IL-1β, IL-6, and monocyte chemoattractant protein (MCP)26. Here, IL1B is linked to pulmonary fibrosis.